Form 8-K - Current report
SEC Accession No. 0001005286-26-000036
Filing Date
2026-09-29
Accepted
2026-09-29 16:12:15
Documents
11
Period of Report
2026-09-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lfcr-20260924.htm   iXBRL 8-K 25598
  Complete submission text file 0001005286-26-000036.txt   141236

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfcr-20260924.xsd EX-101.SCH 1882
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfcr-20260924_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfcr-20260924_pre.xml EX-101.PRE 12603
14 EXTRACTED XBRL INSTANCE DOCUMENT lfcr-20260924_htm.xml XML 2718
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 261423946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)